The Landscape of MET Exon 14 Skipping Mutations in Patients With Lung Cancer Identified by Next-Generation Sequencing
Introduction: MET exon 14 (METex14) skipping mutations are observed in approximately 0.9% to 4% of patients with NSCLC. This study aimed to compare the detection rates of METex14 skipping in Chinese patients with lung cancer using DNA-based next-generation sequencing (NGS) with capture-based library...
Shranjeno v:
| Principais autores: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2025-07-01
|
| Serija: | JTO Clinical and Research Reports |
| Teme: | |
| Online dostop: | http://www.sciencedirect.com/science/article/pii/S2666364325000426 |
| Oznake: |
Brez oznak, prvi označite!
|
